Penumbra, Inc. Set to Showcase Innovations at Canaccord Genuity Conference

Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

Penumbra, Inc. (NYSE: PEN) has announced its participation in the Canaccord Genuity 45th Annual Growth Conference scheduled for August 12, 2025. This event, which will be held in the heart of the financial district, provides a significant platform for the company to showcase its latest technological advancements.

Scheduled for 12:30 PM ET / 9:30 AM PT, the presentation will feature insights from the management team, elaborating on the company's mission and cutting-edge innovations within the medical field. The conference represents a confluence of health technology leaders and potential investors eager to understand the trajectory of companies like Penumbra that are revolutionizing healthcare solutions.

Fans of Penumbra will be able to access a live webcast of this insightful presentation on the company's official website, specifically in the "Events and Presentations" section under the "Investors" tab. This webcast will be available for viewing for at least two weeks following the conference, allowing a broader audience to engage with the vital developments discussed.

About Penumbra, Inc.

Renowned for being the world's leading thrombectomy company, Penumbra focuses on creating groundbreaking solutions for complex medical conditions such as ischemic strokes and venous thromboembolisms, including pulmonary embolisms and acute limb ischemia. Their advanced products, including the innovative computer-assisted vacuum thrombectomy (CAVT), exemplify the company’s commitment to enhancing healthcare delivery. By utilizing these technologies, Penumbra is dedicated to improving patient outcomes across the globe, supporting healthcare providers in over 100 countries, and leaving a lasting impact on quality of life.

The Canaccord Genuity 45th Annual Growth Conference is not just a platform for Penumbra to present its advancements; it also signifies the company's ongoing dedication to its core mission of innovation in the medical field. This event comes at a crucial time for healthcare technology companies as they seek to bridge gaps in patient care and tackle urgent medical challenges.

The management team's involvement in such prominent events illustrates Penumbra's strategy of maintaining investor relations and engaging in dialogue regarding their business initiatives and future advancements."

Overall, Penumbra's participation in the Canaccord Genuity 45th Annual Growth Conference positions it as a leader in thrombectomy technology, reaffirming its role at the forefront of health innovation. As the date approaches, industry professionals, investors, and health advocates are eager to gain insights into what groundbreaking developments Penumbra will unveil.